K12 Training for Clinical and Translational Oncology Researchers

临床和转化肿瘤学研究人员的 K12 培训

• 批准号: 10647170
• 负责人: Erik Sulman
• 金额: $ 5.35万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-20 至 2028-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10647170
• 关键词: Address; Cancer Patient; Clinical; Clinical Oncology; Clinical Research; Clinical Sciences; Clinical Trials; Collaborations; Computational Biology; Creativeness; Dedications; Development; Educational Status; Ensure; Exposure to; Faculty; Fostering; Grant; Individual; Informatics; Infrastructure; Institution; Instruction; Investments; Malignant Neoplasms; Manuscripts; Medical Oncologist; Mentored Clinical Scientist Development Program; Mentors; Performance; Preparation; Productivity; Publications; Radiation Oncologist; Research; Research Personnel; Research Project Grants; Resources; Science; Surgical Oncologist; Time; Training; Translational Research; Work; Writing; anticancer research; career; career development; clinical training; cohort; expectation; experience; innovation; multidisciplinary; next generation; preservation; programs; research and development; responsible research conduct; skill acquisition; skills; success; translational impact; translational oncology

Abstract: A critical requirement to sustain the rapid advances in clinical oncology research that have been made over the last 20 years is to train and mentor the next generation of cancer clinician-investigators. Individuals who can write and carry out clinical trials that will promote increasing benefit for cancer patients are a crucial resource that must be preserved. The objectives of the NYU K12 Program are to provide the protected time which will foster the creativity, drive, and intellectual skills necessary to produce investigators who will make the key clinical discoveries in cancer research over the next few decades. We seek to equip scholars with career development skills that will guide them through productive careers as clinician-investigators. This first-time proposal is based on a record of training and mentoring outstanding clinical researchers while serving as junior faculty at NYU, the provision of a strong institutional commitment to support development of clinician investigators, representation of experienced and motivated medical, radiation and surgical oncologists among the mentors, an emphasis on informatics and computational biology and critical infrastructure that is part of an institutional Clinical and Translational Science Institute (CTSI) to leverage the strengths of the greater institution. NYU K12 scholars will complete training on the responsible conduct of research, general and targeted formal didactics instruction addressing proficiency in clinical and translational research, Master’s-level training in multidisciplinary clinical research, specialized course work, training in team science, individualized and didactic training in grant preparation, exposure to alternative career opportunities, and mentored performance of an innovative high- impact translational research project. Expectations at completion include publication of 2-3 first and/or senior author manuscripts and submission of a K- or R-level grant or equivalent. Three scholars yearly will dedicate 75% effort to research and career development activities for up to three years each, supervised by mentors with extensive and outstanding mentoring experience. A strongly invested K12 Executive Committee and a broad and diverse program faculty will promote each scholar’s mentoring. Our first aim is to provide personalized mentoring and didactic training to advance the clinical and translational research careers of our cohort of K12 scholars. Our second aim is to allow the K12 scholars to identify, choose and pursue research opportunities relevant to advancing the field of clinical oncology. Our third aim is to enable K12 scholars to establish multidisciplinary clinical and translational research networks and collaborations to ensure the success of their efforts and promote their careers in clinical oncology research.

抽象的： 维持临床肿瘤研究快速进步的关键要求已在 最近20年是培训和指导下一代癌症临床治疗剂。可以的人 编写并进行临床试验，该试验将促进癌症患者增加益处的增加是至关重要的资源 必须保留。 NYU K12程序的对象是提供受保护的时间 培养创造创造力，驱动和智力技能，以产生将成为关键临床的调查人员 在接下来的几十年中，癌症研究的发现。我们试图为学者提供职业发展 可以指导他们作为临床评估者的生产力职业的技能。这个首次提案是基于的 在培训和心理杰出的临床研究人员的记录中，在纽约大学的初级教职员工任职期间 提供强大的机构承诺，以支持临床研究人员的发展，代表 导师中有经验和成熟的医学，辐射和外科肿瘤学家 信息和计算生物学和关键基础设施是机构临床的一部分 转化科学研究所（CTSI）利用更大机构的优势。 NYU K12学者将 一般和针对性的正式教学说明完成有关负责任的研究的完整培训 解决临床和翻译研究的水平，多学科临床的硕士学位培训 研究，专业课程工作，团队科学培训，格兰特的个性化和教学培训 准备，接触替代职业机会，并改善了创新的高级表现 影响翻译研究项目。完成时的期望包括第一和/或高级的2-3发布 作者手稿和提交K-或R级赠款或同等学历。每年三个学者将奉献 75％的努力在研究和职业发展活动中最多三年，由导师监督 丰富而杰出的心理经验。大力投资的K12执行委员会和一个广泛的 潜水员计划的教师将促进每个学者的心理。我们的第一个目的是提供个性化 指导和教学培训，以推动我们K12同类的临床和翻译研究职业 我们的第二个目标是允许K12学者识别，选择和寻求研究机会 与促进临床肿瘤学领域有关。我们的第三个目标是使K12学者建立 多学科临床和翻译研究网络和合作，以确保其成功 努力并促进他们在临床肿瘤学研究中的职业。